Table II.

Percentage of correct responses by doctors and nurses regarding pharmacovigilance before and after an educational intervention.

Questions	Nurses (N = 115)			Doctors (N = 42)
	Pre-intervention - % of correct answer	Post-intervention - % of correct answer	Difference in % of correct pre- and post-intervention scores	Pre-intervention - % of correct answer	Post-intervention - % of correct answer	Difference in % of correct pre- and post-intervention scores
1. What is pharmacovigilance?	91.30	98.26	6.96	76.2	97.6	24.4
2. Objectives of spontaneous reporting	38.26	38.26	0.00	38.1	59.5	21.4
3. Who can report ADRs?	93.04	93.91	0.87	95.2	100	4.8
4. Regulatory body for ADR monitoring	73.91	94.78	20.79	97.6	100	2.4
5. What is materiovigilance?	61.74	78.26	16.52	90.5	100	9.5
6. Tool for online reporting - Vigiflow	64.35	97.39	33.04	71.4	92.9	21.5
7. Common adverse effect of drugs	65.22	84.35	19.13	69	88.1	19.1
8. Forms for reporting ADRs	44.35	80.87	36.52	47.6	95.2	47.6
9. Causality assessment scales	42.61	92.17	49.56	33.3	54.8	21.5
10. Number of reports required to generate signal	33.91	82.61	48.70	23.8	50	26.2
11. Number of medical device monitoring centres in India	55.65	96.52	40.87	31	57.1	26.1
12. Languages in which consumer ADR reporting is available	62.61	97.39	34.78	40.5	50	9.5
13. ICH guideline regarding ICSR reporting	63.48	97.39	33.91	28.6	54.8	26.2
14. Naranjo scale - score for “definite” ADR	53.04	89.57	36.53	26.2	54.8	28.2
15. PvPI - year of inauguration	66.09	96.52	30.43	19	42.9	23.9
16. What is included under pharmacovigilance?	53.91	84.35	30.44	73.8	83.3	9.5
17. WHO-UMC causality assessment scale - number of categories	58.26	93.91	35.65	35.7	69	33.3
18. Centres for reporting of adverse event due to medical devices	34.78	78.26	43.48	35.7	78.6	42.9
19. Number of ADR monitoring centres in India	67.83	95.65	27.82	42.9	90.5	47.6
20. Phases of clinical trial	1.74	0.00	-1.74	78.6	90.5	11.9